🥸intro to psychology review

CB1 Receptors

Written by the Fiveable Content Team • Last updated August 2025
Written by the Fiveable Content Team • Last updated August 2025

Definition

CB1 receptors are a type of G protein-coupled receptor that are primarily found in the central nervous system and play a crucial role in the endocannabinoid system. They are the main targets of the psychoactive compound THC found in cannabis, and their activation can lead to various physiological and psychological effects.

AP course connection

Topic 4.5: 4.5 Substance Use and Abuse

Unit 4

5 Must Know Facts For Your Next Test

  1. CB1 receptors are the most abundant G protein-coupled receptors in the brain and are found in high concentrations in regions associated with cognition, memory, pain perception, and motor control.
  2. Activation of CB1 receptors by endocannabinoids or exogenous compounds like THC can lead to a range of effects, including altered perception, mood changes, appetite stimulation, and reduced pain sensitivity.
  3. CB1 receptors play a key role in the regulation of neurotransmitter release, modulating the activity of various neurotransmitter systems, such as GABA, glutamate, and dopamine.
  4. Disruptions in the endocannabinoid system and CB1 receptor function have been implicated in various neurological and psychiatric disorders, including addiction, anxiety, depression, and chronic pain.
  5. CB1 receptors are also found in peripheral tissues, such as the liver, adipose tissue, and skeletal muscle, where they can influence metabolic processes, energy balance, and inflammatory responses.

Review Questions

  • Explain the role of CB1 receptors in the endocannabinoid system and their involvement in the effects of cannabis use.
    • CB1 receptors are the primary targets of the psychoactive compound THC found in cannabis. When THC binds to and activates CB1 receptors, it can lead to a range of physiological and psychological effects, such as altered perception, mood changes, appetite stimulation, and reduced pain sensitivity. This is because CB1 receptors are widely distributed in the central nervous system and play a crucial role in the endocannabinoid system, which regulates a variety of physiological processes, including pain, mood, and memory.
  • Describe the distribution and function of CB1 receptors in the brain and their impact on cognitive and motor processes.
    • CB1 receptors are the most abundant G protein-coupled receptors in the brain and are found in high concentrations in regions associated with cognition, memory, pain perception, and motor control. By modulating the release of various neurotransmitters, such as GABA, glutamate, and dopamine, the activation of CB1 receptors can influence a wide range of cognitive and motor functions. For example, the binding of THC to CB1 receptors can lead to altered perception, mood changes, and impaired motor coordination, as the endocannabinoid system plays a crucial role in regulating these processes.
  • Analyze the potential therapeutic applications and clinical implications of targeting the CB1 receptor system, particularly in the context of substance use disorders and other neurological or psychiatric conditions.
    • Disruptions in the endocannabinoid system and CB1 receptor function have been implicated in various neurological and psychiatric disorders, including addiction, anxiety, depression, and chronic pain. As a result, the CB1 receptor system has become an area of intense research for potential therapeutic interventions. Modulating CB1 receptor activity, either through the development of selective agonists or antagonists, could have therapeutic applications in the treatment of substance use disorders by reducing cravings and withdrawal symptoms, as well as in the management of other conditions, such as chronic pain, mood disorders, and neurodegenerative diseases. However, the complex and widespread nature of the endocannabinoid system and the potential for unintended side effects require careful consideration and further research to fully understand the clinical implications of targeting CB1 receptors.
2,589 studying →